Related Experiment Videos
Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine
Abstract:
D-Glucosamine is toxic to several malignant cell lines and in vivo tumors at concentrations that have little effect upon normal host tissues. Evidence is presented to support the hypothesis that cellular membranes may be the primary targets of glucosamine's tumoricidal activity. Treatment of rat C6 glioma cells with a cytotoxic concentration of glucosamine (20 mM) caused fragmentation of rough endoplasmic reticulum, proliferation of Golgi complexes, evagination of outer nuclear and mitochondrial membranes, and the accumulation of membranous vacuoles and lipid droplets in the cytoplasm. These changes were detected within the first 3 hr after treatment of cultures with glucosamine and became increasingly severe until cell lysis occurred between 24 and 48 hr of treatment. The cytotoxicity of glucosamine was potentiated by the local anesthetic lidocaine, and by other membrane-active drugs, at concentrations that were growth inhibitory but nonlytic. Most of these drugs possessed local anesthetic activity and inhibited glioma sterol synthesis. Within the same period of time required for ultrastructural changes in cellular membranes, glucosamine inhibited the incorporation of [2-(14)C]acetate into sterols and into an unidentified 400-dalton lipid that migrated close to sterols on thin-layer chromatograms. This inhibition was potentiated by lidocaine and increased over the same range of D-glucosamine concentrations that led to increased cell toxicity after a 48-hr treatment. These findings suggest that the effects of glucosamine upon cellular membranes may be central to its tumoricidal activity and that glucosamine, in combination with membrane-active drugs, may be useful in the treatment of certain types of tumors, particularly those of the central nervous system.
Insights
D-Glucosamine exhibits tumoricidal activity by targeting cellular membranes, causing damage to organelles and inhibiting sterol synthesis. Combining D-glucosamine with membrane-active drugs like lidocaine enhances its anti-cancer effects, particularly for central nervous system tumors.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- D-Glucosamine demonstrates selective toxicity towards malignant cells and tumors.
- Its mechanism of action suggests cellular membranes as primary targets.
- Normal host tissues are minimally affected at cytotoxic concentrations.
Purpose of the Study:
- To investigate the hypothesis that cellular membranes are the primary targets of D-glucosamine's tumoricidal activity.
- To elucidate the ultrastructural and biochemical effects of D-glucosamine on cancer cells.
- To explore the potential synergistic effects of D-glucosamine with membrane-active drugs.
Main Methods:
- Treatment of rat C6 glioma cells with D-glucosamine (20 mM).
- Ultrastructural analysis using electron microscopy to observe cellular changes.
- Biochemical assays to measure the incorporation of [2-(14)C]acetate into sterols and lipids.
- Combination treatment with D-glucosamine and lidocaine or other membrane-active drugs.
Main Results:
- D-Glucosamine induced fragmentation of endoplasmic reticulum, Golgi proliferation, and membrane evaginations in glioma cells.
- Cell lysis occurred between 24 and 48 hours post-treatment.
- D-Glucosamine inhibited sterol and lipid synthesis, an effect potentiated by lidocaine.
- Cytotoxicity was enhanced when D-glucosamine was combined with lidocaine and other membrane-active agents.
Conclusions:
- Cellular membranes are likely the principal targets of D-glucosamine's tumoricidal effects.
- D-Glucosamine disrupts membrane integrity and inhibits sterol synthesis in malignant cells.
- Combination therapy with D-glucosamine and membrane-active drugs shows promise for treating tumors, especially those in the central nervous system.